Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Primary care protocol treatment for COPD exacerbations with hospital collaboration
NL-OMON28120Active, not recruiting
- Start
- Nov 2004
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of prednisone in chronic obstructive pulmonary disease (COPD) (2 arms). Primary endpoint: Improvement in patients' health. Started Nov 2004; status: active, not recruiting.
02
Drugs
prednisone
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NL-OMON28120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28120.